| Cell line name | XMMCO-791 |
|---|---|
| Synonyms | 791 |
| Accession | CVCL_F815 |
| Resource Identification Initiative | To cite this cell line use: XMMCO-791 (RRID:CVCL_F815) |
| Comments | Group: Patented cell line. Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9173. Biotechnology: Was used to produce monoclonal antibody MoAb 791T which when conjugated to ricin chain A produces XomaZyme-791 (79IT/36-RTA). XomaZyme-791 was evaluated in two phase 1 clinical trials to treat patients with metastatic colorectal carcinoma (DOI=10.3390/antib1010039). Monoclonal antibody isotype: IgG2b. Monoclonal antibody target: Human colorectal tumour-associated antigen. |
| Species of origin | Mus musculus (Mouse) (NCBI Taxonomy: 10090) |
| Hierarchy | Parent: CVCL_2155 (P3/NS1/1-Ag4.1) |
| Category | Hybridoma |
| Publications | Patent=US4708862 Patent=US4925922 DOI=10.3390/antib1010039 |
| Cross-references | |
| Cell line collections (Providers) | ATCC; HB-9173 |
| Cell line databases/resources | CLO; CLO_0009650 |
| Encyclopedic resources | Wikidata; Q54994847 |
| Entry history | |
| Entry creation | 11-Feb-2013 |
| Last entry update | 21-Mar-2023 |
| Version number | 6 |